Literature DB >> 33425137

Clinical epidemiology and mortality risk factors of gastric cancer in a sub-Saharan African setting: a retrospective analysis of 120 cases in Yaoundé (Cameroon).

Guy Aristide Bang1,2, Eric Patrick Savom1,3, Blondel Nana Oumarou4, Cynthia Karelle Mboupda Ngamy2, Georges Bwelle Moto1,5, Yannick Mahamat Ekani Boukar5, Pierre René Binyom2, Arthur Essomba1,2, Maurice Aurélien Sosso1.   

Abstract

INTRODUCTION: in sub-Saharan Africa, there is scare published data on cancer in general and gastric cancer in particular.
METHODS: we conducted a multicenter retrospective analysis of the medical records of patients followed for gastric cancer in 5 hospital departments in the city of Yaoundé (Cameroon) over 6 years.
RESULTS: we recorded a total of 120 patients with a mean age of 53.4 ± 13.7 years. There were 62 females (51.7%). The most common risk factors for gastric cancer in our patients was Helicobacter pylori infection (59 cases, 49.1%). Seventy-six patients (63.3%) consulted within 1 to 6 months of symptoms on set at the forefront of which chronic epigastralgia (74.1%). At endoscopy, the tumor was mostly located at the antrum and was locally advanced or metastatic in 25.8% and 58.4 of cases respectively. Adenocarcinoma was the main histologic type found in 105 (87.5%) cases. Curative treatment could only be implemented in 26.7% of patients. We noted a total of 85 deaths (70.8%) with a mean survival time of 5.91 ± 7.51 months. Survival rate at 3 and 5 years was 10.1% and 4.6%, respectively. On multivariable analysis, variables independently associated with overall survival included: WHO stage 3 performance status (p = 0.042), palpable epigastric mass on examination (p = 0.042), pyloric localization (p = 0.007), and liver metastasis (p = 0.012).
CONCLUSION: clinical epidemiology of gastric cancer in our study is comparable to those of other African studies with a predominance of locally advanced/metastatic forms. Prognosis is grim with diagnostic delay behind all of the identified mortality risk factors. Copyright: Guy Aristide Bang et al.

Entities:  

Keywords:  Cameroon; Gastric cancer; clinical epidemiology; mortality risk factors; survival

Mesh:

Year:  2020        PMID: 33425137      PMCID: PMC7757231          DOI: 10.11604/pamj.2020.37.104.25422

Source DB:  PubMed          Journal:  Pan Afr Med J


  21 in total

Review 1.  Epidemiology of Helicobacter pylori infection and gastric cancer in Asia.

Authors:  Kwong Ming Fock; Tiing Leong Ang
Journal:  J Gastroenterol Hepatol       Date:  2010-03       Impact factor: 4.029

2.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008.

Authors:  Jacques Ferlay; Hai-Rim Shin; Freddie Bray; David Forman; Colin Mathers; Donald Maxwell Parkin
Journal:  Int J Cancer       Date:  2010-12-15       Impact factor: 7.396

3.  Perigastric lymph node metastases in gastric cancer: comparison of different staging systems.

Authors:  Giovanni de Manzoni; Giuseppe Verlato; Alberto di Leo; Alfredo Guglielmi; Ernesto Laterza; Francesco Ricci; Claudio Cordiano
Journal:  Gastric Cancer       Date:  1999-12       Impact factor: 7.370

Review 4.  Gastric adenocarcinoma: review and considerations for future directions.

Authors:  Bryan J Dicken; David L Bigam; Carol Cass; John R Mackey; Anil A Joy; Stewart M Hamilton
Journal:  Ann Surg       Date:  2005-01       Impact factor: 12.969

Review 5.  Gastric cancer: epidemiology and risk factors.

Authors:  Catherine de Martel; David Forman; Martyn Plummer
Journal:  Gastroenterol Clin North Am       Date:  2013-03-29       Impact factor: 3.806

Review 6.  Gastric cancer in Africa: current management and outcomes.

Authors:  Akwi W Asombang; Rubayat Rahman; Jamal A Ibdah
Journal:  World J Gastroenterol       Date:  2014-04-14       Impact factor: 5.742

7.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.

Authors:  Freddie Bray; Jacques Ferlay; Isabelle Soerjomataram; Rebecca L Siegel; Lindsey A Torre; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-09-12       Impact factor: 508.702

8.  Peritoneal carcinomatosis and lymph node metastasis are prognostic indicators in patients with Borrmann type IV gastric carcinoma.

Authors:  Chin-Yau Chen; Chew-Wen Wu; Su-Shun Lo; Mao-Chin Hsieh; Wing-Yiu Lui; King-Han Shen
Journal:  Hepatogastroenterology       Date:  2002 May-Jun

Review 9.  [Adjuvant chemoradiotherapy in gastric adenocarcinoma: about 34 cases and review of the literature].

Authors:  Laurianne James; Sepos Dossou; Sarah Bellfiq; Joëlle Irigo; Etienne Ogandaga; Karima Mouden; Saïda Loughmari; Dounia Filali; Sanaa El Majjaoui; Tayeb Kebdani; Samir Ahid; Nourredine Benjafaar
Journal:  Pan Afr Med J       Date:  2014-09-24

10.  Trends in Gastric Cancer Incidence According to the Clinicopathological Characteristics in Korea, 1999-2014.

Authors:  Bang Wool Eom; Kyu-Won Jung; Young-Joo Won; Hannah Yang; Young-Woo Kim
Journal:  Cancer Res Treat       Date:  2018-01-15       Impact factor: 4.679

View more
  1 in total

1.  DNA methylation of RNA-binding protein for multiple splicing 2 functions as diagnosis biomarker in gastric cancer pathogenesis and its potential clinical significance.

Authors:  Ming Cheng; Xiaoan Zhan; Yi Xu; Saishan Wang; Hongcheng Zhang; Limin Fang; Hao Jin; Wei Chen
Journal:  Bioengineered       Date:  2022-02       Impact factor: 3.269

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.